469 (Desvenlafaxine Succinate Extended-Release 50 mg)
Pill with imprint 469 is White, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 50 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 469
Desvenlafaxine Succinate Extended-Release
- Imprint
- 469
- Strength
- 50 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1311
- Inactive Ingredients
-
microcrystalline cellulose, hypromelloses, magnesium stearate, polyethylene glycol, silicon dioxide, stearic acid, magnesium silicate, titanium dioxide, xanthan gum
Note: Inactive ingredients may vary.
Related Images for "469"
More about desvenlafaxine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1121 Reviews
- Drug class: serotonin-norepinephrine reuptake inhibitors
Consumer resources
Other brands: Pristiq, Khedezla
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
